Patient resource
RFA vs Laser Ablation for Thyroid Nodules: What Is the Difference?
Radiofrequency and laser ablation both shrink thyroid nodules without surgery. RFA generally achieves greater volume reduction, but the picture is more nuanced.
Radiofrequency ablation and laser ablation both destroy a thyroid nodule from the inside using heat, delivered through a needle or fiber placed under ultrasound guidance. Both are outpatient procedures, both preserve your thyroid, and both avoid a neck incision.
The short answer on which is better: radiofrequency generally achieves greater volume reduction, but the evidence is not unanimous, and for some nodules laser may perform as well or better. Symptom relief, cosmetic improvement, and complication rates are broadly similar between the two.
The more useful answer is that the operator matters more than the technology.
How each one works
Radiofrequency ablation (RFA) passes a rapidly alternating electrical current through a needle electrode. The current agitates ions in the surrounding tissue, and the friction generates heat. The physician moves the electrode continuously through the nodule in small units, a method called the moving-shot technique, building up the treated area zone by zone.
Laser ablation (LA) delivers light energy through one or more ultra-thin optical fibers. The light is absorbed by tissue and converted to heat. The fibers are among the thinnest instruments used in the neck, and they are typically positioned and left in place rather than moved continuously.
The practical difference: RFA produces a larger treatment zone per insertion and is steered actively. Laser produces a smaller, highly predictable zone around each fiber, and larger nodules are treated by placing several fibers at once.
What the evidence shows
The two techniques have been compared directly in randomized trials, which is unusual and useful.
| Measure | RFA | Laser ablation |
|---|---|---|
| Volume reduction at 6 months | 64.3% | 53.2% |
| Volume reduction at 12 months | 70.9% | 60.0% |
| Technical success rate | Similar | Similar |
| Symptom and cosmetic improvement | Significant | Significant |
| Complication rate | No significant difference | No significant difference |
Those figures come from the LARA trials, which randomized patients with benign non-functioning nodules to one technique or the other. At both six and twelve months, RFA achieved greater volume reduction, and the difference was statistically significant.
A separate network meta-analysis reached the same conclusion more strongly, pooling 76.1% mean reduction for RFA against 49.9% for laser.
But the evidence is not one-sided. A propensity-matched study of 2017 found the opposite: laser achieved 70% reduction against 62% for RFA at twelve months, with laser performing notably better in nodules larger than 30 mL. Major complications were identical, four cases in each group.
So the honest summary is that RFA holds an advantage in most published comparisons, the margin is real but not enormous, and at least one good study points the other way.
Where the differences actually matter
Nodule size. RFA’s larger per-insertion treatment zone is an advantage in bigger nodules, and most comparative data favors it there. The propensity-matched study complicates this, so it is worth asking a specialist who offers both what they would choose for your specific nodule.
Proximity to critical structures. Laser’s smaller, more predictable ablation zone can be an advantage when a nodule sits close to the recurrent laryngeal nerve or the trachea. Precision matters more than volume in that situation.
Number of sessions. RFA more often achieves the target reduction in a single session. Laser may require repeat treatment for larger nodules, though this varies by operator and by nodule.
Availability. This is the practical difference most patients actually run into. RFA is far more widely available in the United States, and since January 2025, it has dedicated insurance billing codes. Laser ablation has a longer clinical history in Europe, particularly in Italy, and remains more common there.
What matters more than the choice
Published comparisons measure the technique. They do not measure the person performing it.
The variables that determine your outcome are whether the operator assessed your nodule’s position correctly, whether they used hydrodissection to protect the nerve, whether they treated the full volume rather than the easy center, and how many of these they have performed.
A skilled operator using a laser will get a better result than an inexperienced one using RFA. The reverse is equally true.
One useful signal: Prof. Roberto Valcavi, who has been performing thyroid ablation since 1992, trialed laser, microwave, and high-intensity focused ultrasound before selecting radiofrequency as his primary technique. That is a considered choice rather than a default, and it is worth more than a data table. But it is also his choice for his practice, not a universal verdict.
What to ask
- Which techniques do you offer, and why would you choose that one for my nodule?
- How many of these have you performed?
- Given where my nodule sits, does precision or treatment volume matter more?
- Is one session likely to be enough, or should I expect more?
- If you only offer one technique, who would you refer me to for the other?
A specialist offering a single modality is not, in itself, a problem. A specialist who cannot explain why it suits your case is.
The comparison that matters more
For most patients reading this, the real decision is not RFA against laser. It is an ablation against surgery.
Both techniques preserve your thyroid. Both avoid a neck scar. Both are outpatients. A total thyroidectomy does none of those things and guarantees lifelong hormone replacement.
If you are weighing a surgical recommendation, that is the comparison worth making first.
Get your case reviewed
Which technique suits your nodule depends on its size, composition, and position, and on what your biopsy showed.
Get a second opinion from a specialist who performs ablation, or find a specialist near you.
Related reading
Sources
- Laser Ablation Versus Radiofrequency Ablation for Thyroid Nodules: 12-Month Results of a Randomized Trial (LARA II Study). Journal of Clinical Endocrinology & Metabolism, 106(6):1692. VRR 70.9% RFA vs 60.0% LA at 12 months, P = .024.
- LARA I, 6-month results. RFA 64.3% vs LA 53.2%, P = .015. Adverse events 37% vs 43%, no hospitalizations.
- Comparative efficacy of radiofrequency and laser ablation for benign thyroid nodules: systematic review with Bayesian network meta-analysis. Pooled mean change RFA 76.1% vs LA 49.9%.
- A comparison of laser with radiofrequency ablation for benign thyroid nodules: a propensity score matching analysis, 2017. LA 70% vs RFA 62% at 12 months; LA favored in nodules over 30 mL.
- Radiofrequency Ablation of Benign and Malignant Thyroid Nodules. RadioGraphics. RFA with two treatments achieved the highest mean volume reduction against LA, ethanol, and HIFU; complication rates were not significantly different.